4.34

1.88% 0.08

Bionexus Gene Lab Corp (BGLC)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$4.26

Offen:

$4.06

24-Stunden-Volumen:

42,496

Relative Volume:

0.24

Marktkapitalisierung:

$10.26M

Einnahmen:

$9.26M

Nettoeinkommen (Verlust:

$-941.60K

KGV:

-60.28

EPS:

-0.072

Netto-Cashflow:

$-2.65M

1W Leistung:

-1.36%

1M Leistung:

-17.18%

6M Leistung:

+38.22%

1J Leistung:

+48.17%

1-Tages-Spanne:

$4.0206

$4.34

1-Wochen-Bereich:

$4.00

$4.37

52-Wochen-Spanne:

$2.0068

$15.60

Bionexus Gene Lab Corp Stock (BGLC) Company Profile

Firmenname

Bionexus Gene Lab Corp

Sektor

Basic Materials (272)

Branche

Specialty Chemicals (62)

Telefon

1-307-241-6898

Adresse

10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

BGLC's Discussions on Twitter

Vergleichen Sie BGLC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BGLC BioNexus Gene Lab Corp Common stock	0.343	201.51M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	4.578	9.41B	2.07B	-1.42B	-1.37B	-0.6765
MOBBW Mobilicom Limited Warrants	3.15	4.54B	0	0	0	0.00
GOODO Gladstone Commercial Corporation	20.58	372.90M	0	0	0	0.00
SHMD Schmid Group N V	4.77	208.42M	0	0	0	0.00
DAVEW Dave Inc	0.7242	0	0	0	0	0.00

Bionexus Gene Lab Corp Aktie (BGLC) Neueste Nachrichten

Dec 05, 2025

Is BioNexus Gene Lab Corp. stock safe for conservative investorsWeekly Profit Summary & Stepwise Trade Execution Plans - Newser

Dec 05, 2025

Dec 04, 2025

BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership - MSN

Dec 04, 2025

12 Industrials Stocks Moving In Thursday's Pre-Market Session - Benzinga

Dec 04, 2025

Dec 03, 2025

A Look at BioNexus Gene Lab Corp (BGLC) Shares in the Recent Past Indicates Growth - Setenews

Dec 03, 2025

Blue Gold Sets $15 Million Gold Trading Facility - marketscreener.com

Dec 03, 2025

Bionexus Gene Lab completes strategic investment in Fidelion Diagnostics, secures 15% equity stake in global AI Oncologic platform - MarketScreener

Dec 03, 2025

BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics - Investing.com

Dec 03, 2025

BioNexus Gene Lab Corp. Completes Strategic Transaction with Fidelion Diagnostics, Securing Exclusive Rights for VitaGuard™ in Southeast Asia - Quiver Quantitative

Dec 03, 2025

BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard - marketscreener.com

Dec 03, 2025

BioNexus Gene Lab (NASDAQ: BGLC) acquires 15% Fidelion stake, VitaGuard ASEAN rights - Stock Titan

Dec 03, 2025

Dec 02, 2025

BioNexus Gene Lab secures $500 million equity purchase agreement By Investing.com - Investing.com Nigeria

Dec 02, 2025

BioNexus Gene Lab stock falls after securing $500M equity facility - Investing.com Nigeria

Dec 02, 2025

BioNexus Gene Lab stock falls after securing $500M equity facility By Investing.com - Investing.com South Africa

Dec 02, 2025

BioNexus Gene Lab Shares Jump After Securing $500 Million Equity Facility - MSN

Dec 02, 2025

Bionexus Gene Lab secures $500M equity facility from ARC Group - TipRanks

Dec 02, 2025

BioNexus Gene Lab (BGLC) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

BioNexus Gene Lab secures $500 million equity purchase agreement - Investing.com

Dec 02, 2025

Bionexus Gene Lab Corp enters $500 million equity purchase agreement - marketscreener.com

Dec 02, 2025

BioNexus Gene Lab stock climbs after securing $500 million equity facility - Investing.com UK

Dec 02, 2025

BioNexus Gene Lab stock climbs after securing $500 million equity facility By Investing.com - Investing.com India

Dec 02, 2025

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization - The Manila Times

Dec 02, 2025

BioNexus Gene Lab (Nasdaq: BGLC) lines up $500M ARC equity facility for MRD, CDMO push - Stock Titan

Dec 02, 2025

Dec 01, 2025

Bionexus Gene Lab, Fidelion Diagnostics execute license for VitaGuard platform - TipRanks

Dec 01, 2025

Bionexus Gene Lab Corp to pay $2 million license fee to Fidelion - marketscreener.com

Dec 01, 2025

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene - The Manila Times

Dec 01, 2025

BioNexus Gene Lab (Nasdaq: BGLC) secures royalty-free VitaGuard MRD rights in SE Asia - Stock Titan

Dec 01, 2025

Nov 29, 2025

BioNexus Gene Lab Corp Stock Analysis and ForecastMarket Sentiment Shifts & Hedge Fund-Style Analysis Now Free - earlytimes.in

Nov 29, 2025

Nov 27, 2025

BioNexus Gene Lab Corp. announced that it expects to receive $500 million in funding from ARC Group International Ltd - marketscreener.com

Nov 27, 2025

Nov 26, 2025

Big Picture: How supply chain issues affect BioNexus Gene Lab Corp. stockWeekly Trade Summary & Low Risk High Reward Ideas - BỘ NỘI VỤ

Nov 26, 2025

Nov 25, 2025

BioNexus Gene Lab files $100M shelf registration and establishes $20M at-the-market program - MSN

Nov 25, 2025

Nov 21, 2025

How interest rate cuts could boost BioNexus Gene Lab Corp. stock2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com

Nov 21, 2025

Nov 20, 2025

Will BioNexus Gene Lab Corp. stock outperform growth indexesDividend Hike & Real-Time Stock Entry Alerts - newser.com

Nov 20, 2025

Why BioNexus Gene Lab Corp. stock remains a top recommendation2025 Top Decliners & Proven Capital Preservation Methods - newser.com

Nov 20, 2025

Nov 19, 2025

Is BioNexus Gene Lab Corp. stock reversal real or fakeDay Trade & Breakout Confirmation Trade Signals - newser.com

Nov 19, 2025

Will BioNexus Gene Lab Corp. stock outperform Nasdaq indexQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com

Nov 19, 2025